Three More JD Capital-invested Companies Listed on NEEQ


Recent days saw the official listing on the National Equities and Exchange Quotations (NEEQ) of three more JD Capital-invested companies, namely Shanghai Genon Biological Products Co., Ltd. (Genon Biological, 833946), Xinxiang Sunrise CNC Bearing Equipment Co., Ltd. (Xinxiang Sunrise, 834004), and Wuhan Changlian Laifu Pharmaceutical Limited Liability Company (Changlian Laifu, 834239).

Invested by JD Capital in 2010, Genon Biological focuses on the R&D, production and sales of animal-sourced protein and peptide products, also the import and export of related products and technologies. The company’s flagship product is animal-sourced protein for feeding purpose.

Changlian Laifu Pharmaceutical is dedicated to the R&D, production and sale of anti-infectious agent and drugs for cerebrovascular diseases and digestive disorders mainly in the forms of freeze-dried powder injection, small-volume injection, etc. As an authorized national high-tech enterprise, Changlian Laifu boasts many patents and is fully qualified with industrial product manufacture license, drug manufacturing certificate, Good Manufacturing Practice (GMP) certificate granted by China Food and Drug Administration, and drug registration approvals, etc. JD Capital bought 13.38% of the company’s stock in 2011. 

Xinxiang Sunrise is a domestically-leading supplier of Computer Numerical Control (CNC) bearing equipment, specializing in the R&D, production and sales of bearing rings and bearing rollers of CNC equipment. With the widest selection of products in the bearing industry, the company is one of the few domestic bearing manufacturers that can undertake the precision machining of the full set of bearing components. JD Capital purchased 4.76% of the company’s stock in 2012.

As of now, a total number of 47 JD Capital-invested companies from different industries and sectors have been listed on the NEEQ。